Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Use of Intravenous Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography ; A Randomized Control Trial

NCT06111872 is registered in ClinicalTrials.gov with National University of Malaysia as lead sponsor.

NCT NCT06111872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06111872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Use of Intravenous Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography ; A Randomized Control Trial
Lead sponsor
National University of Malaysia
Phase
Phase 2
Overall status
Completed
Start date
July 18, 2023
Completion date
October 25, 2024
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangitis, choledochal cyst, choledocholithiasis, pancreatic cancer